2022

Pandemic Endgame: What ‘Endemic’ Covid Means—And When We May Get There

Forbes | February 2022

Experts hope COVID-19 will evolve to be more like the common cold

NPR | January 2022

2021

Covid is here for good, scientists say. The rest remains unpredictable

NBC News | December 2021

The Pandemic’s Next Turn Hinges on Three Unknowns

The Atlantic  | November 2021

2020

Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them

New England Journal of Medicine | December 2020

Dr. Halloran awarded a five-year grant for SISMID

The NIAID awarded Dr. Halloran a five-year R25 grant to support the Summer Institute in Statistics and Modeling in Infectious Diseases (SISMID) at the Uninversity of Washington. SISMID is designed to introduce infectious disease researchers to modern methods of statistical analysis and mathematical modeling and to introduce statisticians and mathematical modelers to the statistical and dynamic problems posed by modern infectious disease data. 

2019

Dr. M. Elizabeth ‘Betz’ Halloran elected to National Academy of Medicine

Hutch News | October 2019
The National Academy of Medicine is an independent organization of leading professionals from diverse fields whose work is relevant to health and medicine. Each year, current members of the Academy elect new members who have made major professional contributions to human health and demonstrate a commitment to service.

2018

Dr. Betz Halloran chair-elect of AAAS Section on Statistics

Hutch News | January 2018
The AAAS Section on Statistics is one of 24 groups that direct the organization’s activities, including planning symposia, electing fellows and educating the general public about science.

2017

To protect, or to enhance? That is the question for Dengue virus antibodies

Science Spotlight | December 2017
In work published in Science, a cross-institute collaboration involving Dr. Betz Halloran from the Vaccine and Infectious Disease Division at Fred Hutch studied the relationship between preexisting Dengue virus antibodies and disease severity in a large pediatric Nicaraguan cohort.

Reconstructing Zika’s travels in the Americas

Science Spotlight | June 2017
In a study published in PNAS, researchers created a data driven stochastic spatial epidemic model to analyze the spread and magnitude of Zika virus infection in the Americas. 

2016

Dr. Betz Halloran collects research award in Rome

Hutch News | October 2016
Dr. Betz Halloran received the Aspen Institute Italia Award for her research on the impact that Ebola treatment centers had in curbing the epidemic in Liberia. She was one of 10 scientists from five organizations who shared the prize for co-authoring the winning analysis, originally published in 2015 in the journal The Lancet Infectious Diseases.

Tracking the rise and fall of Ebola in Sierra Leone

Hutch News | March 2016
A team of biostatisticians including Fred Hutch’s Dr. Betz Halloran published a study showing how the Ebola virus impacted Liberia, and offered insight on interventions that worked to curb the disease's spread.

2015

Ebola lessons applied to vaccine clinical trials

Hutch News | April 2015
In a perspective published in Science, researchers from Fred Hutchinson Cancer Research Center and other institutions drew on lessons learned in the ongoing Ebola epidemic in West Africa to suggest guidelines for conducting vaccine clinical trials during an infectious disease emergency.

2014

Fred Hutchinson Cancer Research Center designated MIDAS Center of Excellence

News Releases | September 2014
Models of Infectious Disease Agency Study (MIDAS) centers are designated to play a role in planning for national emergencies such as a pandemic or an act of bioterrorism. Dr. Betz Halloran heads the new MIDAS center, one of only three such sites across the nation.